Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
Date:9/22/2011
>
2009-2016 ($ MILLIONS) 144
TABLE 80 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
EUROPE, 2010 (%) 145
FIGURE 56 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR
EUROPE, 2010 (%) 145
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE
FORMULATIONS 145
Market Overview 145
Market Revenue 146
TABLE 81 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 147
FIGURE 57 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 147
TABLE 82 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR
EUROPE, THROUGH 2016 ($ MILLIONS) 148
FIGURE 58 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, FOR
EUROPE, 2009-2016 ($ MILLIONS) 148
TABLE 83 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
EUROPE, 2010 (%) 149
FIGURE 59 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR
EUROPE, 2010 (%) 149
CONTRACT MANUFACTURE OF ADVANCED DRUG
DELIVERY PRODUCTS 149
Market Overview 150
TABLE 84 CONTRACTING COMPANIES PROVIDING DRUG
DELIVERY SYSTEMS 151
Market Revenue 151
TABLE 85 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY
CONTRACT MANUFACTURING, FOR EUROPE, THROUGH 2016 ($
BILLIONS) 152
FIGURE 60 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY
CONTRACT MANUFACTURING, FOR EUROPE, 2009-2016 ($
BILLIONS) 152
Market by Formulation 152
TABLE 86 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,
THROUGH 2016 ($ MILLIONS) 153
FIGURE 61 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, FOR
EUROPE, 2009-
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America
2. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe
3. Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients
4. Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management
5. Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection
6. Auxilium Pharmaceuticals Announces Additional Data from Three-Year XIAFLEX® Recurrence Study in Dupuytrens Contracture in E-poster at ASSH Meeting
7. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
8. Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application
9. China Contract Research Organization (CRO) Industry Report, 2010-2011
10. Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veterans Administration
11. Pharmaceutical Contract Manufacturing and API Sourcing in Central Europe and the Balkan States 2011
Post Your Comments:
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... systems, announced today that the United States Food and ... Drug application(IND) for ORMD-0801, its oral insulin capsule. ... clearance to proceed," stated Nadav Kidron ... major milestone for Oramed and we look forward to ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...
(Date:5/16/2013)... Therapeutics, (Nasdaq: NKTR ) President and Chief Executive ... to present at the upcoming 2013 UBS Global Healthcare Conference ... New York Hotel on Tuesday, May 21, 2013 at 10:00 ... via a Webcast through a link posted in the Investor ... . This Webcast will be available for replay until June ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2... Inc. (NYSE: WLP ) announced today that ... the Centers for Medicare & Medicaid Services (CMS) to ... (DME MAC) for Jurisdiction B, which includes the states ... National Government Services was originally awarded ...
... Inc. (OTC Bulletin Board: AEMD ), ... address infectious disease and cancer, disclosed today that ... Hemopurifier® within U.S. Government programs that support the ... threats. The Aethlon Hemopurifier® is the first medical ...
Cached Medicine Technology:WellPoint Subsidiary Wins Durable Medical Equipment Medicare Administrative Contract Valued at $86.7 Million 2Aethlon Medical Reestablishes Biodefense Programs 2Aethlon Medical Reestablishes Biodefense Programs 3Aethlon Medical Reestablishes Biodefense Programs 4Aethlon Medical Reestablishes Biodefense Programs 5Aethlon Medical Reestablishes Biodefense Programs 6(Date:5/18/2013)... According to the the Stevens Johnson Syndrome Foundation, Stevens ... a severe allergic reaction usually to medicine (i). The ... quickly advance causing blistering and large areas of dead skin. ... can develop at any time and seriously affect both children ... Bol, passed away after he received kidney medicine which caused ...
(Date:5/18/2013)... 2013 The product liability attorneys at Wright ... behalf of consumers nationwide who have sustained serious tendon injuries ... These cases are all part of MDL 2308 and were ... will be heard in the U.S. District Court of ... & Schulte, LLC specializes in defending the rights of those ...
(Date:5/17/2013)... 17, 2013 Daily Gossip announced on Monday ... creator of the Program Yourself Thin regime, Jim ... online website by the end of the month in order ... successfully reeducate themselves and lead a healthy lifestyle, free of ... Thin package is available for only $97 and it ...
(Date:5/17/2013)... 17, 2013 Degenerative changes to the area ... felt with compression, known as the nucleus pulposus, has been ... a new study led by researchers at the Icahn School ... the journal PLOS ONE, reinforces the importance of diabetes in ... it is the first study to demonstrate that these changes ...
(Date:5/17/2013)... York, New York (PRWEB) May 17, 2013 ... firm dedicated to protecting the rights of victims injured ... (J&J)’s DePuy Orthopaedics Inc. has said in a May ... selling some of its metal-on-metal and ceramic-on-metal hip replacement ... Articulation and the Complete Ceramic-on-Metal Acetabular Hip System will ...
Breaking Medicine News(10 mins):Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 4Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3[0] Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome[0] Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups[0] Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine[0] Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice[0] Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products
... TAMPA, Fla., Nov. 2 Romark Laboratories, ... phase II clinical trial showing that 79% of ... nitazoxanide plus,the standard of care had a sustained ... weeks following treatment, compared to 43%,of patients receiving ...
... Kensey Nash Corporation,(Nasdaq: KNSY ) today ... Optical Coherence Domain Reflectometry Guidewire, from Lawrence,Livermore National ... related to its chronic total occlusion (CTO) platform.,The ... capabilities,allowing it to sense locations, thickness, and structure ...
... Amedisys, Inc.,(Nasdaq: AMED or the "Company"), one of America,s ... Graham, President and,Chief Operating Officer, and Dale E. Redman, ... Markets 18th Annual Healthcare Conference in,New York on Tuesday, ... 9:10 a.m. Eastern time. The audio,presentation will be webcast ...
... Nov. 2 NxStage Medical, Inc.,(Nasdaq: NXTM ), ... machine, today announced its financial results for the,third quarter ... quarter of 2007 were $11.6 million, compared to,$5.5 million ... 111%. Revenues in,the chronic home dialysis market were $8.3 ...
... 2 Vista Partners announced,today that it has ... RPTP). "We believe Raptor,s operational approach will serve,as ... as it promotes,operational efficiency, reduced operating costs and ... a Phase II candidate for 2008 in,Convivia(TM), which ...
... (Nasdaq: KOSN ) will announce its third ... after market close. The announcement of Kosan,s ... a conference call and live webcast on November ... Eastern. Interested parties may access the,live call by ...
Cached Medicine News:Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 2Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 3Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 4Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 2Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 3Health News:Amedisys to Present at 2007 CIBC Healthcare Conference in New York 2Health News:NxStage Medical Reports Third Quarter 2007 Results 2Health News:NxStage Medical Reports Third Quarter 2007 Results 3Health News:NxStage Medical Reports Third Quarter 2007 Results 4Health News:NxStage Medical Reports Third Quarter 2007 Results 5Health News:NxStage Medical Reports Third Quarter 2007 Results 6Health News:NxStage Medical Reports Third Quarter 2007 Results 7Health News:NxStage Medical Reports Third Quarter 2007 Results 8Health News:Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. 2Health News:Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results 2Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis CKensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion PlatformAmedisys to Present at 2007 CIBC Healthcare Conference in New YorkNxStage Medical Reports Third Quarter 2007 ResultsVista Partners Updates Coverage on Raptor Pharmaceuticals Corp.Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
Inquire...
Thermometer for Round Water Bath...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |